Rhinocerebral mycosis in immunocompromised patients. A case report and review of the literature. | Canada Hyperbarics Skip to main content
Case Study Rhinology 1998

Rhinocerebral mycosis in immunocompromised patients. A case report and review of the literature.

Schmidt JM, Poublon RM — Rhinology, 1998

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers presented a case report of rhinocerebral mycosis in an immunocompromised patient and reviewed the relevant medical literature.

What They Found

They found that early diagnosis, based on histological examination and CT scans, is crucial for rhinocerebral mycosis in immunocompromised patients. Prompt systemic treatment with amphotericin B and aggressive surgical debridement are recommended, while prophylactic intranasal amphotericin B may also be beneficial.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a case report and literature review, this study's findings are limited in their generalizability to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Study
Category Neurological
Source Pubmed
PubMed ID 9695166
Year Published 1998
Journal Rhinology
MeSH Terms Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Child; Debridement; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperbaric Oxygenation; Immunocompromised Host; Male; Middle Aged

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology